178 related articles for article (PubMed ID: 24751104)
1. Neurokinin-1 receptor expression and antagonism by the NK-1R antagonist maropitant in canine melanoma cell lines and primary tumour tissues.
Borrego JF; Huelsmeyer MK; Pinkerton ME; Muszynski JL; Miller SA; Kurzman ID; Vail DM
Vet Comp Oncol; 2016 Jun; 14(2):210-24. PubMed ID: 24751104
[TBL] [Abstract][Full Text] [Related]
2. The neurokinin 1 receptor regulates peritoneal fibrinolytic activity and postoperative adhesion formation.
Cassidy MR; Sheldon HK; Gainsbury ML; Gillespie E; Kosaka H; Heydrick S; Stucchi AF
J Surg Res; 2014 Sep; 191(1):12-8. PubMed ID: 24836694
[TBL] [Abstract][Full Text] [Related]
3. Clinical Applications of Substance P (Neurokinin-1 Receptor) Antagonist in Canine Medicine.
Sharun K; Jambagi K; Arya M; Aakanksha ; Chaithra SN; Patel PK; Dixit SK; Dhama K
Arch Razi Inst; 2021 Nov; 76(5):1175-1182. PubMed ID: 35355772
[TBL] [Abstract][Full Text] [Related]
4. Expression of substance P and its neurokinin-1 receptor on thymocytes: functional relevance in the regulation of thymocyte apoptosis and proliferation.
Santoni G; Amantini C; Lucciarini R; Pompei P; Perfumi M; Nabissi M; Morrone S; Piccoli M
Neuroimmunomodulation; 2002-2003; 10(4):232-46. PubMed ID: 12584411
[TBL] [Abstract][Full Text] [Related]
5. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
[TBL] [Abstract][Full Text] [Related]
6. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
[TBL] [Abstract][Full Text] [Related]
7. Elevated SP/NK-1R in esophageal carcinoma promotes esophageal carcinoma cell proliferation and migration.
Dong J; Feng F; Xu G; Zhang H; Hong L; Yang J
Gene; 2015 Apr; 560(2):205-10. PubMed ID: 25659767
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin-1 receptor antagonism improves postoperative neurocognitive disorder in mice.
Li Z; Luo T; Ning X; Xiong C; Wu A
Neurosci Lett; 2018 Nov; 687():189-195. PubMed ID: 30273701
[TBL] [Abstract][Full Text] [Related]
9. The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer.
Muñoz M; González-Ortega A; Salinas-Martín MV; Carranza A; Garcia-Recio S; Almendro V; Coveñas R
Int J Oncol; 2014 Oct; 45(4):1658-72. PubMed ID: 25175857
[TBL] [Abstract][Full Text] [Related]
10. Aprepitant limits in vivo neuroinflammatory responses in a rhesus model of Lyme neuroborreliosis.
Martinez AN; Burmeister AR; Ramesh G; Doyle-Meyers L; Marriott I; Philipp MT
J Neuroinflammation; 2017 Feb; 14(1):37. PubMed ID: 28202084
[TBL] [Abstract][Full Text] [Related]
11. A Novel Mechanism of Endoplasmic Reticulum Stress- and c-Myc-Degradation-Mediated Therapeutic Benefits of Antineurokinin-1 Receptor Drugs in Colorectal Cancer.
Shi Y; Wang X; Meng Y; Ma J; Zhang Q; Shao G; Wang L; Cheng X; Hong X; Wang Y; Yan Z; Cao Y; Kang J; Fu C
Adv Sci (Weinh); 2021 Nov; 8(21):e2101936. PubMed ID: 34605226
[TBL] [Abstract][Full Text] [Related]
12. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the anti-inflammatory and analgesic properties of maropitant: A systematic review and meta-analysis.
Kinobe RT; Miyake Y
Vet J; 2020; 259-260():105471. PubMed ID: 32553233
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage.
Scholzen TE; Steinhoff M; Sindrilaru A; Schwarz A; Bunnett NW; Luger TA; Armstrong CA; Ansel JC
FASEB J; 2004 Jun; 18(9):1007-9. PubMed ID: 15084523
[TBL] [Abstract][Full Text] [Related]
15. Chronic non-peptide neurokinin receptor antagonist treatment alters striatal tachykinin peptide and receptor gene expression in the rat.
McCarson KE; Krause JE; McLean S
Neurosci Lett; 1998 Jul; 251(2):113-6. PubMed ID: 9718987
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.
Guo CJ; Douglas SD; Gao Z; Wolf BA; Grinspan J; Lai JP; Riedel E; Ho WZ
Glia; 2004 Nov; 48(3):259-66. PubMed ID: 15390113
[TBL] [Abstract][Full Text] [Related]
17. Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.
Berger M; Neth O; Ilmer M; Garnier A; Salinas-Martín MV; de Agustín Asencio JC; von Schweinitz D; Kappler R; Muñoz M
J Hepatol; 2014 May; 60(5):985-94. PubMed ID: 24412605
[TBL] [Abstract][Full Text] [Related]
18. The substance P/neurokinin-1 receptor system in lung cancer: focus on the antitumor action of neurokinin-1 receptor antagonists.
Muñoz M; González-Ortega A; Rosso M; Robles-Frias MJ; Carranza A; Salinas-Martín MV; Coveñas R
Peptides; 2012 Dec; 38(2):318-25. PubMed ID: 23026680
[TBL] [Abstract][Full Text] [Related]
19. The neurokinin-1 receptor antagonist LY306,740 blocks nociception-induced increases in dorsal horn neurokinin-1 receptor gene expression.
McCarson KE; Krause JE
Mol Pharmacol; 1996 Nov; 50(5):1189-99. PubMed ID: 8913350
[TBL] [Abstract][Full Text] [Related]
20. The anti-inflammatory action of maropitant in a mouse model of acute pancreatitis.
Tsukamoto A; Ohgoda M; Haruki N; Hori M; Inomata T
J Vet Med Sci; 2018 Mar; 80(3):492-498. PubMed ID: 29343664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]